Profiles of Drug Substances, Excipients and Related Methodology 2013-05-01

Paroxetine hydrochloride.

David Germann, George Ma, Feixue Han, Anna Tikhomirova

Index: Profiles Drug Subst. Excip. Relat. Methodol. 38 , 367-406, (2013)

Full Text: HTML

Abstract

Paroxetine hydrochloride (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine hydrochloride (or (-)-(3S,4R)-(4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)-phenoxy]methyl]piperidine hydrochloride), a phenylpiperidine derivative, is a selective serotonin reuptake inhibitor. Paroxetine is indicated for the treatment of depression, generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, and social anxiety disorder. The physicochemical properties, spectroscopic data (1D and 2D NMR, UV, FT-IR, MS, PXRD), stability, methods of preparation and chromatographic methods of analysis of pharmaceutical, and biological samples of paroxetine are documented in this review. Pharmacokinetics, metabolism, and pharmacological effects are also discussed.


Related Compounds

Related Articles:

A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.

2013-02-01

[J. Clin. Psychopharmacol. 33(1) , 3-10, (2013)]

Chronic angle-closure glaucoma related to paroxetine treatment.

2013-07-01

[Semin. Ophthalmol. 28(4) , 244-6, (2013)]

Paroxetine (Brisdelle) for hot flashes.

2013-10-28

[Med. Lett. Drugs Ther. 55(1428) , 85-6, (2013)]

FDA Approval of Paroxetine for Menopausal Hot Flushes

2014-05-08

[N. Engl. J. Med. 370(19) , 1777-9, (2014)]

Serotonin and yawning: a potential adverse drug reaction during antidepressant therapy

2013-10-16

[Presse Med. 43(10 Pt 1) , 1135-6, (2014)]

More Articles...